Abstract
Importance
Depression is a leading cause of disease burden worldwide, and associated with higher risk of mortality in western populations.
Objective
To investigate whether depression is a risk factor for all-cause and cardiovascular mortality in Chinese adults.
Design, Setting, and Participants
We prospectively followed 512,712 adults (302,509 women and 21,0203 men) aged 30-79 years (mean 52.0, SD 10.7) in the China Kadoorie Biobank (CKB) study from 2004 to 2016, and 26,298 adults (14,508 women and 11,790 men) aged 32 to 104 years (mean 63.6, SD 7.8) in the Dongfeng-Tongji (DFTJ) study from 2008 to 2016.
Main Outcomes and Measures
Depression was evaluated by a Chinese version of the World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF) in the CKB study and a 7-item symptoms questionnaire (modified from CIDI-SF) in the DFTJ study. Multivariable-adjusted Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for the association between depression and mortality. Covariates in the final models included socio-demographic characteristics, lifestyle factors, personal and family medical history.
Results
We documented 44,065 and 2571 total deaths (including 18,273 and 1013 cardiovascular deaths) in the CKB and DFTJ studies, respectively. In the multivariable-adjusted model, depression was associated with an increased risk of all-cause and cardiovascular mortality in both cohorts, and the HR (95% CI) was 1.32 (1.20-1.46) for all-cause mortality and 1.22 (1.04-1.44) for cardiovascular mortality in the CKB cohort, and the corresponding HR (95% CI) was 1.17 (1.06-1.29) and 1.32 (1.14-1.53) in the DFTJ cohort. The associations were consistently found to be stronger in men while weaker or not significant in women for the two outcomes in the two cohorts, although the P values for interaction were not entirely significant.
Conclusions and Relevance
Depression was related to an elevated risk of all-cause and cardiovascular mortality in Chinese adults, particularly in men. Our findings highlight the importance and urgency of depression management as a measure of preventing premature deaths in China.
Keywords: Depression, All-cause mortality, Cardiovascular mortality, Prospective cohort study, Chinese
Depression becomes increasingly common and is one of the leading disease burdens worldwide. The estimated current prevalence of major depressive disorder was 4.7% and the estimated annual incidence rate was 3.0% around the world.1 The Global Burden of Disease Study 2016 reported that more than 34 million all-age disability-adjusted life-years (DALYs) were attributed to depression.2 A recent meta-analysis showed that the overall estimation of current, 12-month and lifetime prevalence of major depressive disorder in China was 1.6%, 2.3%, and 3.3%, respectively.3 It was estimated that over 10 million loss of DALYs were due to depressive disorders in China in 2013 and the number was projected to increase about 10% by 2025,4 which highlights the importance and urgency of prevention and intervention on depression.
Numerous studies have been performed regarding the association between depression and increased risk of all-cause and cause-specific mortality in general populations and various patient groups, as summarized in a recent meta-analysis.5 The meta-analysis included 293 studies with 1,813,733 participants from 35 countries, and found that depression was associated with a 52% increased risk of total mortality.5 However, the causal relationship between depression and mortality is still questionable, and a recent analysis of 293 studies with 3,604,005 participants indicated that the positive depression-mortality association was largely based on low-quality studies (i.e., studies with small sample sizes and short follow-up durations, inadequate adjustment of potential confounding factors, particularly comorbid mentor disorders and health behaviors).6 Therefore, more high-quality work is still needed to examine the depression-mortality association.
Nevertheless, very few prospective cohort studies have been conducted in Chinese adults on this topic. Four studies were found in Chinese adults with three of them in elderly Chinese aged 65 and above and one study in Chinese aged 55 and above.7–10 Three studies found that the association between depressive symptoms and total mortality were stronger in men than that in women.7,9,10 However, studies in younger Chinese adults are lacking and some meta-analyses found that depression also related to excess mortality in women, although not as much as in men.11 Therefore, more cohort studies are urgently needed to examine the relations of depression with all-cause and cardiovascular mortality in Chinese populations.
In the current analysis, we used data from two large, well-established prospective cohort studies in mainland China to investigate whether depression was associated with all-cause and cardiovascular mortality in middle-aged and elderly Chinese. We also tested whether the associations could be modified by age and sex.
Methods
Study Populations
The study design and baseline characteristics of the two cohorts have been reported in detail elsewhere previously.12,13 Briefly, the China Kadoorie Biobank (CKB) cohort is a prospective study with over 0.5 million individuals aged 30-79 years recruited from 10 areas between 2004 and 2008. The Dongfeng-Tongji (DFTJ) cohort was established in 2008-2010 with a total of 27,009 workers from Dongfeng Motor Cooperation with an age range of 32 to 104 years (majority of them were retired workers). At baseline, the estimated population response rate was about 30% (26-38% in the five rural areas and 16-50% in the five urban areas) in CKB cohort12 and 87% in DFTJ cohort13, respectively. In the CKB study, a detailed data collection protocol was developed in Chinese by experts from the Oxford University, local, regional and national Centers for Disease Control and Prevention of China, as part of a robust training program for the field workers and interviewers. Within a few weeks of the initial baseline survey, about 3% of participants were randomly selected to repeat selected items in the questionnaire (depression was not included) and measures as a quality control (QC) procedure. There was good agreement between baseline and QC surveys for several common variables.12 Regular central monitoring, as well as on-site monitoring visits were also undertaken periodically by provincial CDC staff and Oxford/Beijing staff. In the DFTJ cohort, all interviewers received unified training and assessment before the field work, and they administered questionnaires during face-to-face interviews. The on-site QC teams checked all questionnaires for missing and incorrect items every day, and the QC supervision team randomly checked 10% of the questionnaires every week, but a QC resurvey was not conducted in the DFTJ cohort. In the CKB cohort, we excluded participants with unreliable information on death date (n=1) and individuals without information on BMI (n=2). In the DFTJ cohort, we excluded participants without sufficient information on depression (n=1), individuals with unreliable information on death date (n=1) and individuals lost to follow-up (n=709). The CKB study protocol was approved by the Oxford University Tropical Research Ethics Committee and the Chinese Center for Disease Control and Prevention (CDC) Ethical Review Committee, and the DFTJ cohort was approved by the Medical Ethics Committee of the Tongji Medical College, Huazhong University of Science and Technology, and Dongfeng General Hospital, Dongfeng Motor Cooperation. All participants provided written informed consents before enrolment in the study.
Assessment of Depression
In the CKB baseline, participants were firstly asked whether they had the symptoms for two weeks or more in a row during the past 12 months: 1) feeling much more sad, or depressed than usual; 2) loss of interest in most things like hobbies or activities that usually give you pleasure; 3) felt so hopeless that you had no appetite to eat even your favorite food; and 4) feeling worthless and useless, everything went wrong was your fault and life was very difficult that there was no way out. If they answered “yes” to any of the four questions, they were then further evaluated for major depression using a modified Chinese version of the World Health Organization Composite International Diagnostic Interview-Short Form (CIDI-SF)14 in a face-to-face interview performed by trained health workers. In the CIDI-SF questionnaire, seven additional yes-no questions were asked about symptoms during that two weeks, i.e., losing interest in things, feeling tired or low on energy, weight change, difficulty in sleeping, trouble concentrating, thoughts about death, feeling worthless. Participants who had three or more out of the seven depressive symptoms were classified as having major depression. A previous study reported that the sensitivity and specificity of CIDI questionnaire for major depression in Chinese population were 69.6% and 96.7%, respectively.15
In the DFTJ baseline, the participants were directly asked about the seven depressive symptoms in the past one month without inquiry of the screening questions. The participants with 3 or more symptoms during the past month were defined as having clinical significant depressive symptoms. “Depression” was used thereafter to simplify the terminology in the two cohorts.
Mortality Follow-up
In the CKB study, cause-specific mortality was monitored regularly through officially residential records and death certificates reported to China CDC Disease Surveillance Points system. The vital status of the participants was also checked annually against medical and health insurance records and supplemented by the street committee or village administrators, and if necessary, a verbal autopsy was conducted.12 In the DFTJ cohort, each participant had a unique medical insurance card number and was tracked through the medical insurance system of the company for the cause-specific mortality.13 Causes of death were coded according to the International Statistical Classification of Diseases and Related Health Problems Tenth Revision (ICD-10) by the trained staff. The cardiovascular deaths were coded I00-99.
Assessment of Covariates
Information on the covariates in the two cohorts were collected through questionnaires and physical measurement at the baseline survey by trained health workers, including demographic or socioeconomic characteristics (age, sex, education, and marital status for both cohorts and region and household income for CKB study), lifestyle factors (drinking and smoking status, physical activity, and consumption of red meat, fresh fruits and vegetables) and health status. The physical examinations included body weight and height, blood pressures and blood glucose in the two cohorts (random blood glucose in the CKB study and fasting blood glucose in the DFTJ cohort). Participants were asked about their history of chronic diseases, and a health index was created by counting the number of chronic diseases, including chronic obstructive pulmonary disease (COPD)/asthma, hypertension (measured blood pressure ≥140/90 mmHg, or self-reported diagnosis of hypertension or taking antihypertensive drugs at baseline), coronary heart disease (CHD), stroke, diabetes (self-reported diagnosis or medication use, or fasting glucose ≥7.0 mmol/L, or random glucose ≥11.1 mmol/L), and cancer. The health index variable was further categorized into four groups based on the number of chronic diseases: 0, 1, 2, and 3 or more. Physical activity was quantified as metabolic equivalent task hours per day (MET hours/day) spent on work and leisure activities for both farmers and non-farmer. Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters.
Statistical Analysis
Baseline characteristics of the respondents in our study were showed as means (±SD) for continuous variables, or percentages (%) for categorical variables based on their depression status, and Student t test or χ2 test was used to test the differences, respectively. Survival time was defined as the period from the date of baseline interview to the date of death, loss to follow-up, or December 31, 2016 for both cohorts, whichever came first. The association between depression and mortality was estimated using Cox proportional hazards regression model, which yielded hazard ratios (HRs) and corresponding 95% confidence intervals (CIs). The proportional hazards assumption was tested by adding an interaction term of follow-up duration and depression variable in the models and no violation was found. We adjusted the socio-demographic characteristics, lifestyle factors, personal and family medical history as confounders in the multivariable-adjusted Cox models. The potential confounders including: age (continuous variable), sex, education level (less than primary school, middle school, high school and college or higher), BMI (continuous variable), marital status (with and without spouse), drinking status (never, former and current drinking), smoking status (never, former and current smoking), consumption frequency of meat (daily, 4-6 days per week, 1-3 days per week, <1 day per week), vegetables (daily, <1 per day), and fruits (daily, 4-6 days per week, 1-3 days per week, <1 day per week), health index (0, 1, 2, ≥3) and family history of cardiovascular disease (CVD). In the CKB cohort, study site (10 areas) and household income (<10,000, 10,000-19,999, 20,000-34,999, ≥35,000 yuan/year) were also included in the model. The confounders were selected based on a priori knowledge of underlying biological mechanisms and the literature reports.5,6 We also examined the relations of depression with ischemic heart disease (IHD) mortality and cerebrovascular disease mortality. We also conducted stratified analyses by sex and age (≥65 years, or <65 years), and tested the significance of interaction by including a two-way interaction term in the final model.
We performed a series of sensitivity analyses to test the robustness of the results: 1) the individuals who died within the first two years of follow-up were excluded to minimize the chance of reverse causality; 2) participants with baseline cancer, CHD, or stroke were excluded to examine the associations in relatively healthy individuals; 3) participants aged 80 or older in the DFTJ cohort were excluded to reduce the potential selection bias; 4) we adjusted for each chronic disease instead of the health index to fully account for the confounding by disease status. In addition, we also defined depression as having five or more symptoms in both cohorts to examine whether the associations could be changed by applying a more strict cutoff.
We conducted all the analyses separately in each cohort, and the results were pooled together by an inverse variance–weighted meta-analysis approach using the random-effects model. The SAS version 9.3 (SAS Institute, Cary, NC, USA) was used for all analyses and statistical significance level was set to 0.05.
Results
We included 512,712 participants (mean [SD] age, 52.0 [10.7] years; 302,509 [59.0%] women) in the CKB cohort and 26,298 individuals (mean [SD] age, 63.6 [7.8] years; 14,508 [55.2%] women) in the DFTJ cohort. The 12-month prevalence of major depressive episode in the CKB study was 0.64%, and the 1-month prevalence of clinical significant depressive symptoms was 17.96% in the DFTJ study. Table 1 shows the distribution of baseline characteristics based on depression status in the two cohorts. Compared to participants without depression, those with depression were more likely to be female and never smokers, to have more comorbidities and higher family history of CVD, while less likely to be in married status, or to eat red meat and fresh fruits daily. In the CKB study, those with depression were more likely to be younger, inactive, never drinkers, to have lower education level, BMI and household income, while in the DFTJ cohort, those with depression were more likely to be current drinkers. In the CKB study, the top three out of the seven symptoms included “losing interest in things”, “feeling tired or low on energy” and “trouble concentrating”, while the top three symptoms in the DFTJ cohort included “trouble concentrating”, “feeling tired or low on energy” and “difficulty in sleeping” (eTable 1).
Table 1. The Distribution of Baseline Characteristics of Participants According to Depression Statusa.
Baseline depression status | ||||||
---|---|---|---|---|---|---|
CKB cohort | DFTJ cohort | |||||
Yes | No | P valueb | Yes | No | P valueb | |
N | 3280 | 509,432 | 4723 | 21,575 | ||
Age (years) | 51.5±10.0 | 52.0±10.7 | <.001 | 63.5±7.8 | 63.6±7.8 | .22 |
Activity, MET-hours/day c | 19.9±14.1 | 21.1 ±13.9 | <.001 | 4.25±6.62 | 4.38±7.18 | .24 |
BMI (continuous, kg/m2) | 23.2±3.4 | 23.7±3.4 | <.001 | 24.5±3.5 | 24.6±3.3 | .21 |
BMI group (kg/m2) | ||||||
<18.0 | 140 (4.3) | 13,927 (2.7) | <.001 | 104 (2.2) | 359 (1.7) | .09 |
18.0-24.9 | 2232 (68.1) | 327,501 (64.3) | 2678 (56.7) | 12,328 (57.1) | ||
25.0-29.9 | 790 (24.1) | 147,156 (28.9) | 1684 (35.7) | 7699 (35.7) | ||
≥30.0 | 118 (3.6) | 20,848 (4.1) | 257 (5.4) | 1189(5.5) | ||
Female (%) | 2331 (71.1) | 300,178 (58.9) | <.001 | 2991 (63.3) | 11,517(53.4) | <.001 |
Residential area | NA | NA | NA | |||
Urban | 1132(34.5) | 225,049(44.2) | ||||
Rural | 2148(65.5) | 284,383(55.8) | ||||
Education (%) | <.001 | .01 | ||||
Less than primary school | 1875 (57.1) | 258,480 (50.7) | 1455 (30.8) | 6481 (30.0) | ||
Middle School | 889 (27.1) | 143,983 (28.3) | 1684 (35.7) | 7721 (35.8) | ||
High School | 386 (11.8) | 77,122 (15.1) | 1155 (24.4) | 5081 (23.6) | ||
College or higher | 130 (4.0) | 29,847 (5.9) | 429 (9.1) | 2292 (10.6) | ||
Household income (yuan/year, %) | <.001 | NA | NA | NA | ||
<10000 | 1339 (40.8) | 143,395 (28.1) | ||||
10000-19999 | 939 (28.7) | 148,017 (29.1) | ||||
20000-34999 | 673 (20.5) | 126,029 (24.7) | ||||
⩾35000 | 329 (10.0) | 91,991 (18.1) | ||||
Marital status (%) | <.001 | <.001 | ||||
Married | 2437 (74.3) | 462,025 (90.7) | 4002 (84.7) | 18,971 (87.9) | ||
Widowed | 638 (19.5) | 35,919 (7.1) | 461 (9.8) | 1669 (7.7) | ||
Separated / divorced | 155 (4.7) | 7787 (1.5) | 247 (5.2) | 872 (4.1) | ||
Never married | 50 (1.5) | 3701 (0.7) | 13 (0.3) | 63 (0.3) | ||
Drinking status (%) | <.001 | <.001 | ||||
Never/ Occasional/ Monthly | 2762 (84.2) | 412,858 (80.5) | 3477 (73.6) | 15,788 (73.2) | ||
Former/ Reduced intake | 194 (5.9) | 20,758 (4.1) | 352 (7.5) | 1181 (5.5) | ||
Current | 1324 (9.9) | 75,816 (14.9) | 894 (18.9) | 4606 (21.3) | ||
Smoking status (%) | <.001 | <.001 | ||||
Never/ Occasional | 2424 (73.9) | 344,209 (67.6) | 3410 (72.2) | 15,089 (69.9) | ||
Former | 146 (4.4) | 30,415 (6.0) | 558 (11.8) | 2545 (11.8) | ||
Current | 710 (21.7) | 134,808 (26.4) | 755 (16.0) | 3941 (18.3) | ||
Red meat (%) | <.001 | <.001 | ||||
Daily | 610 (18.6) | 149,407 (29.3) | 1152 (24.4) | 5843 (27.1) | ||
4-6 days per week | 462 (14.1) | 91,340 (17.9) | 348 (7.4) | 1466 (6.8) | ||
1-3 days per week | 1352 (41.2) | 180,812 (35.5) | 1976 (41.8) | 9186 (42.6) | ||
<1 day per week | 856 (26.1) | 87,873 (17.3) | 1247 (26.4) | 5080 (23.5) | ||
Fresh vegetables (%) | .14 | .08 | ||||
Daily | 3099 (94.5) | 482,837 (94.8) | 4400 (93.2) | 20,246 (93.8) | ||
<1 per day | 181 (5.5) | 26,595 (5.2) | 323 (6.8) | 1329 (6.2) | ||
Fresh fruits (%) | <.001 | .03 | ||||
Daily | 420 (12.8) | 96,162 (18.9) | 2232 (47.3) | 10,715 (49.6) | ||
4-6 days per week | 221 (6.8) | 47,737 (9.3) | 299 (6.3) | 1271 (5.9) | ||
1-3 days per week | 932 (28.4) | 160,357 (31.5) | 1297 (27.5) | 5711 (26.5) | ||
<1 day per week | 1707 (52.0) | 205,176 (40.3) | 895 (18.9) | 3878 (18.0) | ||
Family history of CVD (%) | 847 (25.8) | 104,208 (20.5) | <.001 | 717 (15.2) | 1939 (9.0) | <.001 |
Health index (%) | <.001 | <.001 | ||||
0 | 1921 (58.6) | 306,564 (60.2) | 1076 (22.8) | 6746 (31.3) | ||
1 | 1017 (31.0) | 165,952 (32.6) | 161 (34.2) | 8370 (38.8) | ||
2 | 283 (8.6) | 32,010 (6.3) | 1214 (25.7) | 4553 (21.1) | ||
≥3 | 59 (1.8) | 4906 (0.9) | 819 (17.3) | 1906 (8.8) | ||
Chronic diseases | ||||||
COPD/asthma (%) | 172 (5.2) | 15,125 (3.0) | <.001 | 927 (19.6) | 2487 (11.5) | <.001 |
Hypertension (%) | 1047 (31.9) | 173,405 (34.0) | .01 | 2718 (57.6) | 11,825 (54.8) | <.001 |
CHD (%) | 161 (4.9) | 15,311 (3.0) | <.001 | 1220 (25.8) | 3228 (15.0) | <.001 |
Stroke (%) | 116 (3.5) | 8768 (1.7) | <.001 | 378 (8.0) | 1057 (4.9) | <.001 |
Diabetes (%) | 23 3(7.1) | 30,066 (5.9) | .004 | 1078 (22.8) | 3828 (17.7) | <.001 |
Cancer (%) | 43 (1.3) | 2535 (0.5) | <.001 | 426 (9.0) | 1163 (5.4) | <.001 |
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CHD, coronary heart disease; CKB, China Kadoorie Biobank; CVD, cardiovascular diseases; COPD, chronic obstructive pulmonary disease; DFTJ, Dongfeng-Tongji; NA, data not available.
Data are shown as mean ± standard deviation for continuous variables, or percentage for categorical variables.
P values were calculated by Student t-test for continuous variables or χ2 test for categorical variables.
MET hours/day: metabolic equivalent of task value for a day's work and leisure activities for both farmers and non-farmer.
Depression and All-cause and Cardiovascular Mortality
In the CKB study, we documented 44,065 deaths (including 17,501 cardiovascular deaths) during 5,088,810 person-years of follow-up. In the DFTJ cohort, we documented 2571 deaths (including 1013 cardiovascular deaths) during 208,403 person-years of follow-up. The incidence rate of all-cause and cardiovascular mortality among participants with depression were significantly higher than that among those without depression in both cohorts (Table 2). In the multivariable-adjusted model, depression was associated with an increased risk of all-cause and cardiovascular mortality in both cohorts, and the HR (95% CI) was 1.32 (1.20-1.46) for all-cause mortality and 1.22 (1.04-1.44) for cardiovascular mortality in the CKB cohort, and the corresponding HR (95% CI) was 1.17 (1.06-1.29) and 1.32 (1.14-1.53) in the DFTJ cohort. In the multivariable-adjusted model, the association between depression and IHD mortality and cerebrovascular disease mortality were significant in the model 1 for both outcomes in both cohorts and attenuated when adjusting for health index and family history of CVD, the HR (95% CI) was 1.27(0.97-1.67) for IHD mortality and 1.21 (0.98-1.51) for cerebrovascular disease mortality in the CKB cohort, and the corresponding HR (95% CI) was 1.21 (0.97-1.50) and 1.56 (1.24-1.96) in the DFTJ cohort. (eTable 2 in the Supplement).
Table 2. The Association between Depression and All-cause and Cardiovascular Mortality.
Cases/person-years | Incidence per 1,000 person-years | Unadjusted Model | Model 1a | Model 2b | Depressive symptoms scorec | |
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||
All-cause mortality | ||||||
CKB | ||||||
No depression | 43,681/50,55,739 | 8.64 | 1[Reference] | 1[Reference] | 1[Reference] | 1[Reference] |
Depression | 384/33,071 | 11.61 | 1.56 (1.41-1.73) | 1.39 (1.26-1.54) | 1.32 (1.20-1.46) | 1.06 (1.04-1.08) |
DFTJ | ||||||
No depression | 2027/171,375 | 11.83 | 1[Reference] | 1[Reference] | 1[Reference] | 1[Reference] |
Depression | 544/37,028 | 14.69 | 1.36 (1.24-1.50) | 1.31 (1.19-1.44) | 1.17 (1.06-1.29) | 1.04 (1.02-1.07) |
CVD mortality | ||||||
CKB | ||||||
No depression | 17,501/5,055,739 | 3.46 | 1[Reference] | 1[Reference] | 1[Reference] | 1[Reference] |
Depression | 147/33,071 | 4.44 | 1.48 (1.26-1.74) | 1.31 (1.11-1.54) | 1.22 (1.04-1.44) | 1.04 (1.01-1.07) |
DFTJ | ||||||
No depression | 772/171,375 | 4.50 | 1[Reference] | 1[Reference] | 1[Reference] | 1[Reference] |
Depression | 241/37,028 | 6.51 | 1.59 (1.37-1.84) | 1.55 (1.34-1.80) | 1.32 (1.14-1.53) | 1.08 (1.04-1.12) |
Abbreviation: CI, confidence interval; CKB, China Kadoorie Biobank; CVD, cardiovascular diseases; DFTJ, Dongfeng-Tongji; HR: hazard ratio.
Model 1: adjusted age, sex, education, BMI, spouse, drinking, smoking, consumption of meat, vegetables, and fruits; CKB cohort further adjusted region and household income.
Model 2: adjusted model 1 plus health index and family history of CVD.
The results were calculated by adjusting for confounders shown in Model 2.
Stratified Analysis by Sex and Age
In the stratified analysis by sex, the associations were only significant in men compared to women in both cohorts for both outcomes except for all-cause mortality in CKB cohort. In the CKB cohort, the HR (95% CI) for all-cause mortality was 1.53 (1.32-1.76) in men and 1.19 (1.03-1.37) in women (P for interaction = .005), while the HR (95% CI) for cardiovascular mortality was 1.39 (1.10-1.76) in men and 1.11 (0.89-1.40) in women. In the DFTJ cohort, the HR (95% CI) for all-cause mortality was 1.24 (1.10-1.41) in men and 1.06 (0.91-1.24) in women, while the HR (95% CI) for cardiovascular mortality was 1.49 (1.23-1.80) in men and 1.09 (0.86-1.39) in women (Table 3).
Table 3. The Association between Depression and All-cause and Cardiovascular Mortality: Stratified Analysis by Sex.
Case/person-years | Incidence per 1,000 person-years | HR (95% CI)a | P for interactionb | |
---|---|---|---|---|
All-cause mortality | ||||
CKB | ||||
Male | 25,151/2,049,266 | 12.27 | 1.53 (1.32-1.76) | .005 |
Female | 18,914/3,039,543 | 6.22 | 1.19 (1.03-1.37) | |
DFTJ | ||||
Male | 1659/91,681 | 18.10 | 1.24 (1.10-1.41) | .21 |
Female | 912/116,723 | 7.81 | 1.06 (0.91-1.24) | |
CVD mortality | ||||
CKB | ||||
Male | 9796/2,049,266 | 4.78 | 1.39 (1.10-1.76) | .10 |
Female | 7852/3,039,543 | 2.58 | 1.11 (0.89-1.40) | |
DFTJ | ||||
Male | 656/91,681 | 7.16 | 1.49 (1.23-1.80) | .06 |
Female | 357/116,723 | 3.06 | 1.09 (0.86-1.39) |
Abbreviation: CI, confidence interval; CKB, China Kadoorie Biobank; CVD, cardiovascular diseases; DFTJ, Dongfeng-Tongji; HR, hazard ratio.
The model adjusted age, sex, education, BMI, spouse, drinking, smoking, consumption of meat, vegetables, fruits, health index and family history of CVD; CKB cohort further adjusted region and household income.
The results were calculated by adjusting for confounders shown above.
In the stratified analysis by age, the associations were only significant in older people (aged ≥65 years) compared to younger participants (aged <65 years) in the DFTJ cohort for both outcomes (although the P values for interaction were not significant); however, the associations were only significant in younger compared to older participants in the CKB cohort for both outcomes (P values for interaction <.05) (Table 4).
Table 4. The Association between Depression and All-cause and Cardiovascular Mortality: Stratified Analysis by Age.
Case/person-years | Incidence per 1,000 person-years | HR (95% CI)a | P for interactionb | |
---|---|---|---|---|
All-cause mortality | ||||
CKB | ||||
Age≥65 | 21,230/67,1594 | 31.81 | 1.08 (0.91-1.29) | <.001 |
Age <65 | 22,835/4,417,216 | 5.17 | 1.45 (1.28-1.64) | |
DFTJ | ||||
Age ≥65 | 1858/84,654 | 21.95 | 1.21 (1.08-1.35) | .39 |
Age <65 | 713/123,750 | 5.76 | 1.06 (0.88-1.28) | |
CVD mortality | ||||
CKB | ||||
Age ≥65 | 9838/671,594 | 14.65 | 1.01 (0.78-1.32) | .02 |
Age <65 | 7810/4,417,216 | 1.76 | 1.34 (1.09-1.65) | |
DFTJ | ||||
Age ≥65 | 761/84,654 | 8.99 | 1.33 (1.12-1.58) | .98 |
Age <65 | 252/123,750 | 2.04 | 1.27 (0.94-1.71) |
Abbreviation: CI, confidence interval; CKB, China Kadoorie Biobank; CVD, cardiovascular diseases; DFTJ, Dongfeng-Tongji; HR, hazard ratio.
The model adjusted age, sex, education, BMI, spouse, drinking, smoking, consumption of meat, vegetables, fruits, health index and family history of CVD; CKB cohort further adjusted region and household income.
The results were calculated by adjusting for confounders shown above.
Sensitivity Analysis
The association between depression and mortality remained unchanged in the sensitivity analysis of excluding individuals who died during the first two years of follow-up (CKB cohort: n=5261; DFTJ cohort: n=1204), or excluding participants with baseline history of cancer, CHD, or stroke (CKB cohort: n=25,514; DFTJ cohort: n=6633), or excluding individuals aged 80 or older in the DFTJ cohort (n=533), or using five or more symptoms as the cut-off point to define depression. The associations were slightly attenuated when adjusting for six specific diseases instead of the health index, but did not change materially (eTable 3 in the Supplement).
Discussion
In these two large prospective cohorts of Chinese adults, we found that depression was associated with a significantly elevated risk of all-cause mortality and cardiovascular mortality, and the associations were independent of socio-demographic factors, lifestyle factors, and health status. We further found that the associations were only significant in men. This is, to our knowledge, the first and largest study in mainland China to evaluate the relations of depression with all-cause and cardiovascular mortality.
A large body of evidence has demonstrated that depression is a risk factor for all-cause mortality. Many studies have been done on this topic in the general population as well as specific patient groups, and a meta-analysis of 293 studies with 1,813,733 participants from 35 countries showed that depression was associated with a 52% increased risk of total mortality.5 Among the 293 studies, 78 were done in the community samples and the pooled HR was 1.59 (95% CI 1.47-1.71).5 However, most of the investigations were performed in western countries, and high-quality studies in Chinese populations are lacking. In an early study among 280 adults aged 65 years and older living in a rural community in Taiwan, Fu et al.8 reported that depressive symptoms, defined as the 20-item Center for Epidemiological Studies-Depression Scale (CES-D) score ≥15, were associated with higher mortality risk during 12 years of follow-up (HR, 1.55; 95% CI, 0.99-2.44). In another cohort study of 2416 men and women in Taiwan aged 65 or older, Teng et al.9 reported that depressive symptoms, defined as the 10-item CES-D score ≥10, were associated with higher mortality risk during 8 years of follow-up only in men (HR, 1.27; 95% CI, 1.03-1.56), but not in women (HR, 1.10; 95% CI, 0.86-1.40). In a cohort study of 56,088 men and women in Hong Kong aged 65 or older, Sun et al.7 reported that depressive symptoms, defined as the 15-item Geriatric Depression Scale (GDS) score ≥8, were associated with higher mortality risk during 8 years of follow-up only in men (HR, 1.21; 95% CI, 1.08-1.37), but not in women (HR, 1.00; 95% CI, 0.91-1.10). A recent study among 1999 participants in Beijing reported that time-dependent depressive symptoms, defined as 20-item CES-D score ≥16, were associated with higher mortality risk in men (HR, 1.66; 95% CI, 1.32-2.09) and women (HR, 1.42; 95% CI, 1.13-1.77).10 Therefore, the present study is generally consistent with the literature, and is the largest cohort study on this topic in mainland China. The previous four studies in Chinese populations were all in people who aged 55 years and older, and our study also included people younger than 55 years old. In the stratified analysis by age, the associations were not consistently found in the CKB and DFTJ cohorts. The exact reasons for this disparity are unknown and more prospective studies are needed to explore whether age-specific associations exist for depression and mortality.
We also observed that the depression-mortality association was more evident in men. This is consistent with three previous studies in the elderly Chinese in Taiwan, Hong Kong and Beijing.7,9,10 In a recent meta-analysis, Miloyan & Fried evaluated the sex differences in the depression-mortality relation.6 They found 33 estimates in men and 29 in women, and reported that the association was slightly stronger in men (HR, 1.41; 95% CI, 1.29-1.54) than that in women (HR, 1.23; 95% CI, 1.13-1.32).6 Therefore, the current evidence suggests that there might be a potential sex difference in the depression-mortality association. Although the exact reasons for the sex difference are unclear, there are several potential biological and psychosocial explanations. First, depression associated oxidative stress16–18 may explain the sex difference. Mounting evidence suggests that men express remarkably lower levels of antioxidants (superoxide dismutase19 and glutathione20) in mitochondria than women, which would lead to greater oxidative damage in men. Second, although the prevalence of depression is generally higher in women compared to men, the strategies to overcome depression might be different. Compared to women, men are culturally less inclined to report mild depression or seek help until depression is in severe status.21,22 In addition, the emotional processing in general in the brain is different in men and women, as indicated in some studies using functional magnetic resonance imaging.23,24 Finally, some previous studies25,26 have examined a number of risk factors related to CHD/stroke that might be different in men and women, and the underlying biological, behavioral, or social mechanisms are still unclear.
We also found that depression was associated with significantly higher risk of cardiovascular mortality in the two cohorts of Chinese adults. Mounting evidence has showed that depression is a risk factor of cardiovascular mortality both in general population and in patients with known heart diseases, and a recent meta-analysis of 92 studies with 116,295,136 participants showed that depression was associated with a 63% higher risk of cardiovascular mortality.27 Among the 92 studies, 7 were done in community samples and the pooled HR was 1.63 (95% CI, 1.25-2.13).27 A meta-analysis of myocardial infarction (MI) and coronary events from 19 cohort studies with 323,709 participants and 8447 cases reported that depression was associated with a significantly increased risk of deaths of MI (HR, 1.31; 95% CI, 1.13-1.32) and coronary events (HR, 1.36; 95% CI; 1.14-1.63).28 Another meta-analysis of stroke morbidity and mortality among 317,540 participants from 28 prospective cohort studies reported depression was associated with a 55% increase risk of stroke mortality.29 Similar to all-cause mortality, most of the studies on cardiovascular mortality were conducted in western countries, and high-quality studies in Chinese populations are lacking. In a cohort study of 62,839 participants in Hong Kong aged 65 or older, Sun et al.30 reported that depressive symptoms, defined as the 15-item GDS score ≥8, were associated with higher CHD mortality risk during 8.4 years of follow-up only in men (HR, 1.41; 95% CI, 1.08-1.84), but not in women (HR, 0.94; 95% CI, 0.75-1.16). In the cohort study among 1999 participants in Beijing, Li et al.10 reported that time-dependent depressive symptoms were associated with higher cardiovascular mortality risk in men (HR, 1.59; 95% CI, 1.09-2.30), but not in women (HR, 1.23; 95% CI, 0.85-1.79). Therefore, the present study is generally consistent with the previous studies in this field. In addition, our previous analyses in the CKB study found that depression was associated with higher risks of incident IHD31 and stroke.32 The results of current analysis of depression and cardiovascular mortality were consistent with these results.
Previous studies had proposed several potential causal mechanisms for association between depression and mortality but there is no consensus yet.5,33 Biologically, depression may cause dysregulation of central biological stress systems, including hypothalamic-pituitary-adrenal axis hyperactivity,34 neuroimmune and sympathoadrenergic dysregulation,35 which might all play a role in the association between depression and mortality. In addition, people with depression usually have unhealthy lifestyles,36 including physical inactivity, smoking, heavy alcohol consumption, and poor diet patterns and low adherence to treatment, and those factors have been consistently shown to be causal risk factors for premature death. As for cardiovascular mortality, previous studies reported that depression was associated with vascular endothelial dysfunction,37 a prolonged QT interval,38 lower heart rate variability,36 and increased platelet aggregation,37 which would accelerate the deterioration of the condition.
Several strengths should be noted in the current study. To our knowledge, this is the largest study to investigate the association between depression and mortality in Chinese population. Participants from the CKB study were recruited from ten areas (five urban and five rural) across China, while participants from the DFTJ cohort were mostly from retired workers from a large company and most of them were living in the Shiyan City in central China. The characteristics of the participants in the two cohorts were different in many ways. The consistent results from the two cohort studies indicate that the findings might not be by chance. Furthermore, we collected detailed information on outcomes, followed-up a relative long time with the high follow-up rate, and adjusted for a number of potential confounding factors.
Several limitations should be noted in our study. First, the DFTJ cohort is an occupational cohort and healthy worker effect might be possible. However, the prevalence of clinical relevant depressive symptoms was similar to that in a meta-analysis of Chinese adults in the similar age range.39 In the CKB study, the 12-month prevalence of depression detected by CIDI-SF was quite low (0.61%) compared to findings from previous studies in Western and Chinese populations,40–42 which may be because of different depression measurement tools and procedures and study populations. The CKB study only recruited those who volunteered to participate, while more depressed patients would be less likely to be included because of their loss of interest in most things. In addition, the symptoms were asked differently which may also cause misclassifications, i.e. 2-week duration in the past 12 months in the CKB, and any time in the past 1 month in the DFTJ and we did not have the screening questions before asking the participants of the 7 symptoms in the DFTJ cohort. Despite the difference in the depression measurement and substantial differences in the prevalence of depression in the two cohorts, the consistent results in the two cohorts, again, reduced the possibility of chance findings. Second, we did not have clinical diagnosis of depression and its subtypes in our studies and did not measure depression status during the follow-up, thus, misclassifications of the depression status were possible. Further studies are also needed to investigate the long-term impact of different types of depression (e.g., melancholic and atypical depression) on health outcomes.43 We used two different criteria to define depression in our analyses (having at least 3 symptoms in the main analysis and having at least 5 symptoms in the sensitivity analysis), the results remained similar, indicating that the cut-off points to detect depression did not change our findings. Furthermore, the misclassifications were more likely to be non-differential and were unrelated to the outcome, thus may underestimate the associations. Third, we did not collect the detailed information of anti-depressants use for people with depression. However, previous analysis in the CKB study44 and some studies in the Chinese population41 indicate that the proportion of people with depression who received treatment is low. Therefore, the influence of anti-depressant treatment on the results would be minimal. Finally, residual confounding is still possible although we have adjusted for various established and potential risk factors of mortality in the present study.
Conclusions
In conclusion, depression was an independent risk factor of all-cause mortality and cardiovascular mortality in the Chinese adults, especially in men. More studies with clinically diagnostic depression and repeated measures of depression are still needed to confirm our findings in Chinese populations and clarify the potential underling mechanisms. Given the high disease burdens by depression and CVD in the general population, and the substantial low treatment rate in Chinese population,44 our findings have significant clinical and public health importance, and more efforts are needed in China to increase the awareness and improve the treatment strategies for patients with depression.
Supplementary Material
Key points.
Question: Is depression associated with higher all-cause and cardiovascular mortality in Chinese adults?
Finding: During the 5,088,810 and 208,403 person-years of follow-up of China Kadoorie Biobank (CKB) cohort and Dongfeng-Tongji (DFTJ) cohort, we respectively documented 44,065 and 2571 all-cause deaths (including 17,501 and 1013 cardiovascular deaths). The results of two cohorts consistently showed that depression was associated with higher risk of all-cause and cardiovascular mortality, and the associations were significant only in men.
Meaning: Depression is a risk factor for all-cause and cardiovascular mortality in Chinese adults, particularly in men.
Acknowledgments
We thank all the participants and research staff who took part in the Dongfeng-Tongji cohort for their contributions. We also thank the participants, the project staff, and the China National Centre for Disease Control and Prevention (CDC) and its regional offices for assisting with the fieldwork of the China Kadoorie Biobank study, in particular, we thank Judith Mackay, FRCP (Chinese University of Hong Kong); YuWang, PhD, Gonghuan Yang, PhD, Zhengfu Qiang, MD, Lin Feng, MSc, Maigeng Zhou, PhD, Wenhua Zhao, PhD, and Yan Zhang, BD (China CDC); Lingzhi Kong,MD, Xiucheng Yu, MD, and Kun Li, MD (Chinese Ministry of Health); and Sarah Clark, DPhil, Martin Radley, BSc, Michael Hill, DPhil, Hongchao Pan, PhD, and Jill Boreham, PhD (Clinical Trial Service Unit, Oxford University), who assisted with the design, planning, organization, and conduct of the study. None of the aforementioned contributors received compensation for their contributions.
Sources of Funding
The analysis was specifically supported by the National Key Research and Development Program of China (2017YFC0907504) and the National Natural Science Foundation of China (81202266). The DFTJ cohort was supported by the National Key Research and Development Program of China (2016YFC0900800, 2016YFC0900801, 2017YFC0907500, and 2017YFC0907501), and the National Natural Science Foundation of China (91643202 and 81230069). The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up of CKB is supported by grants from the UK Wellcome Trust (202922/Z/16/Z, 088158/Z/09/Z, 104085/Z/14/Z), the National Natural Science Foundation of China [81390540, 81390541, and 81390542], the National Key Research and Development Program of China (2016YFC0900500, 2016YFC0900501, and 2016YFC0900504), and the Chinese Ministry of Science and Technology (2011BAI09B01).
Role of the Funder/Sponsor
The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Members: Members of the China Kadoorie Biobank Collaborative Group include the following:
International Steering Committee: Junshi Chen, Zhengming Chen (PI), Rory Collins, Liming Li (PI), Richard Peto. International Co-ordinating Centre, Oxford: Daniel Avery, Ruth Boxall, Derrick Bennett, Yumei Chang, Yiping Chen, Zhengming Chen, Robert Clarke, Huaidong Du, Simon Gilbert, Alex Hacker, Mike Hill, Michael Holmes, Andri Iona, Christiana Kartsonaki; Rene Kerosi, Ling Kong, Om Kurmi, Garry Lancaster, Sarah Lewington, Kuang Lin, John McDonnell, Iona Millwood, Qunhua Nie, Jayakrishnan Radhakrishnan, Sajjad Rafiq, Paul Ryder, Sam Sansome, Dan Schmidt, Paul Sherliker, Rajani Sohoni, Becky Stevens, Iain Turnbull, Robin Walters, Jenny Wang, Lin Wang, Neil Wright, Ling Yang, Xiaoming Yang. National Co-ordinating Centre, Beijing: Zheng Bian, Yu Guo, Xiao Han, Can Hou, Jun Lv, Pei Pei, Yunlong Tan, Canqing Yu. 10 Regional Co-ordinating Centres: Qingdao CDC: Zengchang Pang, Ruqin Gao, Shanpeng Li, Shaojie Wang, Yongmei Liu, Ranran Du, Yajing Zang, Liang Cheng, Xiaocao Tian, Hua Zhang, Yaoming Zhai, Feng Ning, Xiaohui Sun, Feifei Li. Licang CDC: Silu Lv, Junzheng Wang, Wei Hou. Heilongjiang Provincial CDC: Mingyuan Zeng, Ge Jiang, Xue Zhou. Nangang CDC: Liqiu Yang, Hui He, Bo Yu, Yanjie Li, Qinai Xu,Quan Kang, Ziyan Guo. Hainan Provincial CDC: Dan Wang, Ximin Hu, Hongmei Wang, Jinyan Chen, Yan Fu, Zhenwang Fu, Xiaohuan Wang. Meilan CDC: Min Weng, Zhendong Guo, Shukuan Wu,Yilei Li, Huimei Li, Zhifang Fu. Jiangsu Provincial CDC: Ming Wu, Yonglin Zhou, Jinyi Zhou, Ran Tao, Jie Yang, Jian Su. Suzhou CDC: Fang liu, Jun Zhang, Yihe Hu, Yan Lu, Liangcai Ma, Aiyu Tang, Shuo Zhang, Jianrong Jin, Jingchao Liu. Guangxi Provincial CDC: Zhenzhu Tang, Naying Chen, Ying Huang. Liuzhou CDC: Mingqiang Li, Jinhuai Meng, Rong Pan, Qilian Jiang, Jian Lan,Yun Liu, Liuping Wei, Liyuan Zhou, Ningyu Chen Ping Wang, Fanwen Meng, Yulu Qin,, Sisi Wang. Sichuan Provincial CDC: Xianping Wu, Ningmei Zhang, Xiaofang Chen,Weiwei Zhou. Pengzhou CDC: Guojin Luo, Jianguo Li, Xiaofang Chen, Xunfu Zhong, Jiaqiu Liu, Qiang Sun. Gansu Provincial CDC: Pengfei Ge, Xiaolan Ren, Caixia Dong. Maiji CDC: Hui Zhang, Enke Mao, Xiaoping Wang, Tao Wang, Xi zhang. Henan Provincial CDC: Ding Zhang, Gang Zhou, Shixian Feng, Liang Chang, Lei Fan. Huixian CDC: Yulian Gao, Tianyou He, Huarong Sun, Pan He, Chen Hu, Xukui Zhang, Huifang Wu, Pan He. Zhejiang Provincial CDC: Min Yu, Ruying Hu, Hao Wang. Tongxiang CDC: Yijian Qian, Chunmei Wang, Kaixu Xie, Lingli Chen, Yidan Zhang, Dongxia Pan, Qijun Gu. Hunan Provincial CDC: Yuelong Huang, Biyun Chen, Li Yin, , Huilin Liu, Zhongxi Fu, Qiaohua Xu. Liuyang CDC: Xin Xu, Hao Zhang, Huajun Long, Xianzhi Li, Libo Zhang, Zhe Qiu.
Footnotes
Author Contributions: Dr. Pan, Dr. Z. Chen, and Dr. Li had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Meng and Dr. Yu contributed equally to the article.
Concept and design: Meng, Yu, Pan, Li.
Acquisition, analysis, or interpretation of data: all authors.
Drafting of the manuscript: Meng.
Critical revision of the manuscript for important intellectual content: all authors.
Statistical analysis: Meng, Yu.
Obtained funding: Yu, Guo, Z. Chen, Wu, Pan, Li.
Administrative, technical, or material support: Yu, He, Lv, Guo, Bian, Yang, Y. Chen, Zhang, Z. Chen, Wu, Pan, Li.
Supervision: Z. Chen, Wu, Pan, Li.
Conflicts of Interest Disclosures:
All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Contributor Information
Ruiwei Meng, Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Canqing Yu, Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Na Liu, Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Meian He, Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun Lv, Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Xiaomin Zhang, Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhengming Chen, Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Tangchun Wu, Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
An Pan, Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
MD Liming Li, Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China; Chinese Academy of Medical Sciences, Beijing, China.
References
- 1.Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–481. doi: 10.1017/S0033291712001511. [DOI] [PubMed] [Google Scholar]
- 2.GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–1344. doi: 10.1016/S0140-6736(17)32130-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One. 2013;8(6):e65356. doi: 10.1371/journal.pone.0065356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Charlson F, Baxter A, Cheng H, Shidhaye R, Whiteford H. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet. 2016;388(10042):376–389. doi: 10.1016/S0140-6736(16)30590-6. [DOI] [PubMed] [Google Scholar]
- 5.Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171(4):453–462. doi: 10.1176/appi.ajp.2013.13030325. [DOI] [PubMed] [Google Scholar]
- 6.Miloyan B, Fried E. A reassessment of the relationship between depression and all-cause mortality in 3,604,005 participants from 293 studies. World Psychiatry. 2017;16(2):219–220. doi: 10.1002/wps.20439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sun W, Schooling CM, Chan WM, Ho KS, Lam TH. The association between depressive symptoms and mortality among Chinese elderly: a Hong Kong cohort study. J Gerontol A Biol Sci Med Sci. 2011;66(4):459–466. doi: 10.1093/gerona/glq206. [DOI] [PubMed] [Google Scholar]
- 8.Fu CC, Lee YM, Chen JD. Association between depressive symptoms and twelve-year mortality among elderly in a rural community in Taiwan. J Formos Med Assoc. 2003;102(4):234–239. [PubMed] [Google Scholar]
- 9.Teng PR, Yeh CJ, Lee MC, Lin HS, Lai TJ. Depressive symptoms as an independent risk factor for mortality in elderly persons: results of a national longitudinal study. Aging Ment Health. 2013;17(4):470. doi: 10.1080/13607863.2012.747081. [DOI] [PubMed] [Google Scholar]
- 10.Li H, Van Halm-Lutterodt N, Zheng D, et al. Time-dependent depressive symptoms and risk of cardiovascular and all-cause mortality among the Chinese elderly: The Beijing Longitudinal Study of Aging. J Cardiol. 2018;72(4):356–362. doi: 10.1016/j.jjcc.2018.02.015. [DOI] [PubMed] [Google Scholar]
- 11.Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison. J Affect Disord. 2014;161(6):47–54. doi: 10.1016/j.jad.2014.03.003. [DOI] [PubMed] [Google Scholar]
- 12.Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–1666. doi: 10.1093/ije/dyr120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang F, Zhu J, Yao P, et al. Cohort Profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol. 2013;42(3):731–740. doi: 10.1093/ije/dys053. [DOI] [PubMed] [Google Scholar]
- 14.Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU. The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF) Int J Methods Psychiatr Res. 1998;7(4):171–185. [Google Scholar]
- 15.Lu J, Huang YQ, Liu ZR, Cao XL. Validity of Chinese Version of the Composite International Diagnostic Interview-3.0 in psychiatric settings. Chin Med J (Engl) 2015;128(18):2462–2466. doi: 10.4103/0366-6999.164930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Cancer Science. 2001;92(3):367–376. doi: 10.1111/j.1349-7006.2001.tb01104.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom Med. 2006;68(1):1–7. doi: 10.1097/01.psy.0000195780.37277.2a. [DOI] [PubMed] [Google Scholar]
- 18.Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids. Psychoneuroendocrinology. 2010;35(9):1356–1362. doi: 10.1016/j.psyneuen.2010.03.010. [DOI] [PubMed] [Google Scholar]
- 19.Borrás C, Sastre J, Garcíasala D, Lloret A, Pallardó FV, Viña J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34(5):546–552. doi: 10.1016/s0891-5849(02)01356-4. [DOI] [PubMed] [Google Scholar]
- 20.Viña J, Borrás C, Gambini J, Sastre J, Pallardó FV. Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ. 2005;2005(23):pe17. doi: 10.1126/sageke.2005.23.pe17. [DOI] [PubMed] [Google Scholar]
- 21.Gorman JM. Gender differences in depression and response to psychotropic medication. Gender Medicine. 2006;3(2):93–109. doi: 10.1016/s1550-8579(06)80199-3. [DOI] [PubMed] [Google Scholar]
- 22.Schoevers RA, Beekman ATF, Tilburg WV, et al. Association of depression and gender with mortality in old age. Br J Psychiatry. 2000;177(7):336–342. doi: 10.1192/bjp.177.4.336. [DOI] [PubMed] [Google Scholar]
- 23.Wrase J, Klein S, Gruesser SM, et al. Gender differences in the processing of standardized emotional visual stimuli in humans: a functional magnetic resonance imaging study. Neurosci Lett. 2003;348(1):41–45. doi: 10.1016/s0304-3940(03)00565-2. [DOI] [PubMed] [Google Scholar]
- 24.Koch K, Pauly K, Kellermann T, et al. Gender differences in the cognitive control of emotion: an fMRI study. Neuropsychologia. 2007;45(12):2744–2754. doi: 10.1016/j.neuropsychologia.2007.04.012. [DOI] [PubMed] [Google Scholar]
- 25.Crea F, Battipaglia I, Andreotti F . Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis. 2015;241(1):157–168. doi: 10.1016/j.atherosclerosis.2015.04.802. [DOI] [PubMed] [Google Scholar]
- 26.Bushnell CD, Chaturvedi S, Gage KR, et al. Sex differences in stroke: challenges and opportunities. J Cereb Blood Flow Metab. 2018;38(12):2179–2191. doi: 10.1177/0271678X18793324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163. doi: 10.1002/wps.20420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wu Q, Kling JM. Depression and the risk of myocardial infarction and coronary death: a meta-analysis of prospective cohort studies. Medicine. 2016;95(6):e2815. doi: 10.1097/MD.0000000000002815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241–1249. doi: 10.1001/jama.2011.1282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sun WJ, Xu L, Chan WM, Tai HL, Schooling CM. Are depressive symptoms associated with cardiovascular mortality among older Chinese: a cohort study of 64,000 people in Hong Kong? Am J Geriatr Psychiatry. 2013;21(11):1107–1115. doi: 10.1016/j.jagp.2013.01.048. [DOI] [PubMed] [Google Scholar]
- 31.Liu N, Pan XF, Yu C, et al. Association of major depression with risk of ischemic heart disease in a mega-cohort of Chinese adults: the China Kadoorie Biobank study. J Am Heart Assoc. 2016;5(12):e004687. doi: 10.1161/JAHA.116.004687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sun J, Ma H, Yu C, et al. Association of major depressive episodes with stroke risk in a prospective study of 0.5 million Chinese adults. Stroke. 2016;47(9):2203. doi: 10.1161/STROKEAHA.116.013512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002;53(4):897–902. doi: 10.1016/s0022-3999(02)00311-2. [DOI] [PubMed] [Google Scholar]
- 34.Vreeburg SA, Hoogendijk WJG, Pelt JV, et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009;66(6):617. doi: 10.1001/archgenpsychiatry.2009.50. [DOI] [PubMed] [Google Scholar]
- 35.Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi: 10.1016/j.biopsych.2009.09.033. [DOI] [PubMed] [Google Scholar]
- 36.Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity : a review of potential mechanisms. J Psychosom Res. 2002;53(4):897–902. doi: 10.1016/s0022-3999(02)00311-2. [DOI] [PubMed] [Google Scholar]
- 37.Stapelberg NJC, Neumann DL, Shum DHK, Mcconnell H, Hamiltoncraig I. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust N Z J Psychiatry. 2011;45(5):351. doi: 10.3109/00048674.2011.570427. [DOI] [PubMed] [Google Scholar]
- 38.Whang W, Julien HM, Higginbotham L, et al. Women, but not men, have prolonged QT interval if depressed after an acute coronary syndrome. Europace. 2012;14(2):267–271. doi: 10.1093/europace/eur246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Li D, Zhang DJ, Shao JJ, Qi XD, Tian L. A meta-analysis of the prevalence of depressive symptoms in Chinese older adults. Arch Gerontol Geriatr. 2014;58(1):1–9. doi: 10.1016/j.archger.2013.07.016. [DOI] [PubMed] [Google Scholar]
- 40.Wang F, Zhang QE, Zhang L, et al. Prevalence of major depressive disorder in older adults in China: a systematic review and meta-analysis. J Affect Disord. 2018;241:297–304. doi: 10.1016/j.jad.2018.07.061. [DOI] [PubMed] [Google Scholar]
- 41.Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009;373(9680):2041. doi: 10.1016/S0140-6736(09)60660-7. [DOI] [PubMed] [Google Scholar]
- 42.Ronald C, Kessler P, Patricia Berglund M, Olga Demler M. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication. JAMA. 2003;289:3095–3105. doi: 10.1001/jama.289.23.3095. [DOI] [PubMed] [Google Scholar]
- 43.Baune BT, Stuart M, Gilmour A, et al. The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl Psychiatry. 2012;2:e92. doi: 10.1038/tp.2012.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chen Y, Bennett D, Clarke R, et al. Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women. Psychol Med. 2017;47(5):958–970. doi: 10.1017/S0033291716002889. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.